Suerte, Jacinto E.
HRN: 25-09-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2026
CEFTRIAXONE 1G (VIAL)
01/23/2026
01/30/2026
IV
2g
OD
CAP-MR
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines